Stock NKTX NKARTA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Nkarta, Inc.

Equities

NKTX

US65487U1088

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
6.51 USD +0.70% Intraday chart for Nkarta, Inc. +25.68% -1.36%
Jun. 27 Nkarta Initiates Trial of Cell Therapy to Treat Lupus Nephritis; FDA Clears Second Application MT
Jun. 27 Nkarta, Inc. Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications CI
f0bc7b0c36398eca944e12ad6b119.XLFcNxAnF5NwVxU-Q1QO0JpM0HdbU7MDQkxSpVuTnJc.NNcuckgVX9oKHHlLIj57hvEIsxoeY4NaMxgnkBDc0e8b3G1fJENc2UMPTA~96fadfbdf3981a2a9c5f101c5095f775
  1. Stock Market
  2. Equities
  3. NKTX Stock
  4. Charts Nkarta, Inc.
  5. News Chart